Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220015138 220018262 1.55 null Curative (C) 2015-04-22 2015-04-22 DAUNORUBICIN null null 220033588 CVD
220015139 220018262 null 71.6 Curative (C) 2017-01-07 2017-01-29 Alemtuzumab+Busulfan+CyclophosphMUD null null 220033588 DAUNORUBICIN
220015140 220015156 1.61 61.6 null 2013-09-11 2013-09-15 FIGARO TRIAL N N 220033759 PEMBROLIZUMAB
220015141 220009791 1.56 57 Curative (C) 2015-12-05 2015-12-05 TRASTUZUMAB N N 220033759 HCX
220015142 220009791 null 87.2 Curative (C) 2018-03-27 2018-03-29 CAV 2 null 220033759 PEMBROLIZUMAB
220015143 220009793 1.68 100.9 Disease modification (D) 2016-04-03 2016-06-04 LENALIDOMIDE 2 N 220034037 CAPECITABINE + OXALIPLATIN
220015144 220015159 1.67 66.8 Disease modification (D) 2013-11-08 2013-11-08 Clofarabine+Cytarabine+Idarubicin 02 N 220034048 CAMELLIA TRIAL
220015145 220009796 1.68 16.6 Disease modification (D) 2014-03-23 2014-03-23 FIGARO TRIAL 02 null 220034048 MACE
220015146 220009797 1.8 null Disease modification (D) 2018-01-29 2019-05-05 CISPLATIN + RT null null 220034188 FLUDARABINE
220015147 220015162 1.79 null Curative (C) 2017-09-09 2017-09-15 BUSULFAN + CYCLO 2 N 220034188 EOF
220015148 220009798 1.62 60.3 Curative (C) 2019-06-19 2019-06-20 Bortezomib + Cyclophos + Dex null N 220034295 FLUDARABINE
220015149 220009799 1.65 87.9 null 2018-07-21 2018-07-28 ALL UKALL2011 Maintenance A3 Y N 220034318 DOXORUBICIN
220015150 220009802 null null null 2014-06-26 2014-08-11 LENALIDOMIDE N N 220034508 IGEV R
220015151 220009807 null 80.3 Palliative (P) 2017-10-25 2017-11-02 DAUNORUBICIN N N 220034708 IMATINIB + HYDROXYCARBAMIDE
220015152 220009808 null null Palliative (P) null 2018-01-29 CLOFARABINE + DAUNORUBICIN 99 null 220034781 CARBOPLATIN
220015153 220009810 1.67 94 Curative (C) 2018-03-15 2018-06-25 Arsenic Triox + Tretinoin Ind W1-4 02 N 220034831 LIPOSOMAL CYTARABINE
220015154 220009811 0 46.4 Palliative (P) 2017-09-12 2017-10-14 MERCAPTOPURINE + METHOTREXATE 02 N 220035162 GEMCITABINE
220015155 220009811 null 113 Curative (C) null 2017-05-24 MITOXANTRONE + TRETINOIN null null 220035162 GEMCITABINE
220015156 220009813 1.78 76.7 Curative (C) 2018-04-05 2018-04-05 ALL UKALL2011 Maintenance A1 N N 220035216 PEMBROLIZUMAB
220015157 220009814 1.69 84.8 Curative (C) 2015-05-20 2015-05-20 BUSULFAN + CYCLO N N 220035338 CARBOPLATIN
220015158 220009816 1.63 null Curative (C) 2014-06-07 2014-06-10 EC N null 220035346 VINCRISTINE
220015159 220009817 1.7 65.3 Curative (C) 2015-11-01 2015-11-11 CYCLOPHOSPHAMIDE + THALIDOMIDE 99 N 220035363 CISPLATIN + PEMETREXED
220015160 220009818 null 101.8 Curative (C) 2018-07-22 2018-07-27 MERCAPTOPURINE + METHOTREXATE N N 220035438 PERTUZUMAB + TRASTUZUMAB
220015161 220009818 null null Curative (C) 2013-11-06 2013-11-07 CYTARABINE + Hydrocortisone + Hydrocortisone + METHOTREXATE null null 220035438 CAV
220015162 220020020 0 69.6 Curative (C) 2013-08-17 2013-08-24 Arsenic Trioxide (Induction Week) 02 N 220035628 UKALL2011
220015163 220009821 1.53 63 Curative (C) 2016-02-19 2016-02-20 Ipilimumab 2 N 220014565 CISPLATIN + RT
220015164 220009821 1.8 69.1 null 2016-04-08 2016-04-08 CETUXIMAB + IRINOTECAN + MDG N N 220014565 MERCAPTOPURINE + METHOTREXATE
220015165 220009822 null 99.7 Curative (C) 2014-12-17 2014-12-17 MELPHALAN N N 220020987 EOX
220015166 220009824 null 76 Curative (C) 2016-03-19 2016-04-07 Sorafenib 2 N 220023685 LI-1 TRIAL
220015167 220015170 1.77 89.5 Curative (C) 2019-04-14 2019-05-22 Etoposide oral N N 220024970 RAVVA TRIAL
220015168 220009826 1.66 120 null 2017-12-17 2017-12-21 R GCVP N null 220028568 FLUDARABINE
220015169 220015172 1.74 44.8 Curative (C) 2013-07-09 2013-07-09 Etoposide oral 02 N 220029487 IRINOTECAN
220015170 220009828 1.79 null null 2017-11-19 2017-11-26 IGEV R N null 220032351 CYTARABINE + FLUDARABINE
220015171 220009829 null null Curative (C) 2016-11-03 2016-11-11 Vincristine (weekly) N N 220032604 ETOPOSIDE + IDARUBICIN
220015172 220015173 null 38.95 Palliative (P) 2017-03-06 2017-03-07 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB null null 220035180 CISPLATIN + FLUOROURACIL
220015173 220015173 1.67 62.2 Palliative (P) 2018-09-14 2018-10-26 PEMBROLIZUMAB N N 220035180 PEMBROLIZUMAB
220015174 220015174 1.77 56.6 Curative (C) 2016-02-08 2016-02-09 Methotrexate High Dose (3g/m2) N N 220034624 ALEMTUZUMAB + CYCLO + FLUDARABINE
220015176 220004044 null 115 Disease modification (D) null 2013-12-23 IMATINIB 2 N 220000022 IMATINIB
220015177 220012143 null null Disease modification (D) 2015-03-29 2015-03-29 IMATINIB N N 220000089 IMATINIB
220015178 220004047 null null Disease modification (D) 2016-04-26 2016-04-26 Imatinib 400mg null N 220000097 IMATINIB
220015179 220004050 1.69 71 Disease modification (D) 2013-04-25 2013-05-12 Imatinib 400mg N N 220000120 IMATINIB
220015180 220004053 1.81 150 Disease modification (D) 2015-02-13 2015-02-13 Imatinib 400mg 2 N 220000145 IMATINIB
220015181 220012145 0 0 Disease modification (D) 2018-03-29 2018-04-26 IMATINIB 02 N 220000151 IMATINIB
220015182 220004058 null 0 Curative (C) 2015-11-13 2015-11-13 Imatinib 400mg 02 N 220000211 IMATINIB
220015183 220004060 1.38 78.6 Palliative (P) null 2016-09-21 IMATINIB N N 220000223 IMATINIB
220015185 220004066 null null Disease modification (D) 2017-05-08 2017-12-08 IMATINIB N null 220000374 IMATINIB
220015186 220004068 null 0 Curative (C) 2016-05-23 2017-04-18 IMATINIB 2 N 220000450 IMATINIB
220015187 220004075 0 0 Disease modification (D) 2014-05-31 2014-06-07 Imatinib 400mg N N 220000633 IMATINIB
220015188 220004078 1.55 0 null 2016-11-07 2016-11-08 Imatinib 400mg 2 N 220000637 IMATINIB
220015189 220004079 1.7 null Curative (C) 2012-12-15 2014-01-24 IMATINIB 2 N 220000650 IMATINIB